BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25916726)

  • 1. Emerging Role of Phosphodiesterase 2A in Hypertension.
    Seifert R
    Hypertension; 2015 Jul; 66(1):13-4. PubMed ID: 25916726
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.
    Li D; Lu CJ; Hao G; Wright H; Woodward L; Liu K; Vergari E; Surdo NC; Herring N; Zaccolo M; Paterson DJ
    Hypertension; 2015 Jul; 66(1):190-8. PubMed ID: 25916722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
    Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
    Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
    Tanaka M; Sekioka R; Nishimura T; Ichihara A; Itoh H
    Diabetes Res Clin Pract; 2014 Dec; 106(3):504-10. PubMed ID: 25458339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 2: anti-adrenergic friend or hypertrophic foe in heart disease?
    Wagner M; Mehel H; Fischmeister R; El-Armouche A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1139-1141. PubMed ID: 27553701
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review.
    Woods RL
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):791-4. PubMed ID: 15566395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 2A localized in the spinal cord contributes to inflammatory pain processing.
    Kallenborn-Gerhardt W; Lu R; Bothe A; Thomas D; Schlaudraff J; Lorenz JE; Lippold N; Real CI; Ferreirós N; Geisslinger G; Del Turco D; Schmidtko A
    Anesthesiology; 2014 Aug; 121(2):372-82. PubMed ID: 24758774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dorsal root ganglion axon bifurcation tolerates increased cyclic GMP levels: the role of phosphodiesterase 2A and scavenger receptor Npr3.
    Schmidt H; Peters S; Frank K; Wen L; Feil R; Rathjen FG
    Eur J Neurosci; 2016 Dec; 44(12):2991-3000. PubMed ID: 27740716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).
    Trabanco AA; Buijnsters P; Rombouts FJ
    Expert Opin Ther Pat; 2016 Aug; 26(8):933-46. PubMed ID: 27321640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of cyclic nucleotide phosphodiesterases in the cAMP compartmentation in cardiac cells].
    Mika D; Leroy J; Vandecasteele G; Fischmeister R
    Biol Aujourdhui; 2012; 206(1):11-24. PubMed ID: 22463992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
    Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
    Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides: a new lipolytic pathway in human adipocytes.
    Sengenès C; Berlan M; De Glisezinski I; Lafontan M; Galitzky J
    FASEB J; 2000 Jul; 14(10):1345-51. PubMed ID: 10877827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.
    Kim GE; Kass DA
    Handb Exp Pharmacol; 2017; 243():249-269. PubMed ID: 27787716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic activation by sildenafil.
    Katz SD; Parums DV
    Circulation; 2001 Nov; 104(22):E119-20. PubMed ID: 11723034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.